Inst of Systems, Molecular & Integrative Biology
@LivUniISMIB
Followers
3K
Following
4K
Media
605
Statuses
6K
We're no longer posting to X. Our pinned post contains all the details you need to keep up to date with our Institute news.
University of Liverpool, UK
Joined February 2013
We’re no longer posting to X. The best way to stay in touch with us and read our latest news and updates is to follow us on our other channels. BlueSky: https://t.co/HYruti5URU LinkedIn: https://t.co/1tShnjKrvw Web: https://t.co/O2JXu5jvaQ
0
0
1
NEWS | A £2.3M study is testing a new care approach to help older people with heart failure & frailty stay independent. More info ⬇️ https://t.co/wG5t9DLVPk
0
4
5
Interested in pexophagy? Check out our newly published work: we developed pexophagy reporters for use in Drosophila research. Very happy to have been involved in this collaboration @LivUniISMIB
https://t.co/aJ5jBKlVzZ
royalsocietypublishing.org
Peroxisomes are essential organelles involved in critical metabolic processes in animals such as fatty acid oxidation, ether phospholipid production and reactive oxygen species detoxification. We...
1/8 🚨 New publication alert! 🚨 We developed live #Drosophila melanogaster models with fluorescent reporters to study #pexophagy – the selective autophagy of peroxisomes – in vivo. 🧵👇 @livuninews @wellcometrust @CCI_liv @LivUniHLS
0
4
8
Calling all @livuni PGRs Are you entering the Three Minute Thesis competition? Sign up to the online information session delivered by the Academy with key hints and tips from last year’s winner Dina-Leigh Simons! For more information, go to: https://t.co/VyBAoLw0ZZ
@UoLPGRDevNet
0
2
2
LISTEN I Lecturer @drlornayoung and our widening participation team visited @bbcmerseyside to talk about a #WorldCancerDay event @livuni for local year 12 students to learn more about cancer research and experience attending University ⬇️ From 2h18m:
0
2
2
Leading the way in tackling Cancer in the Liverpool City Region. Meet Professor Tim Maughan, @livuni's Chair of Oncology who works with researchers, the NHS and communities to deliver a 10-year strategy. Watch our video to find out more https://t.co/cBwhXl5Ce6
#WorldCancerDay
0
2
4
Today is #WorldCancerDay and we're proud to be a part of an amazing project developing a new oral cancer diagnosis device, the LDIR Wand💙 The device is being developed by researchers in @livuniphyssci in collaboration with our colleagues at @livHeadandNeck
#TeamLivUni
WATCH | On #WorldCancerDay, we're proud to highlight a new oral cancer diagnosis device, the LDIR Wand, developed by our researchers in collaboration with the Liverpool Head and Neck Centre. 💙 Read the full story ➡️ https://t.co/FgrsTSL7v4
0
1
1
Pleased to report on our experience of ganglioglioma, a rare brain tumour in young people. Recurrence is rare & we don’t advocate MRI surveillance past 5 years after gross total resection. https://t.co/dxgpiL0BVc
@WaltonCentre @LivUniISMIB @_jocn
#neurosurgery #neurooncology
1
1
9
NEWS | @LivUni researcher first recipient of prestigious Medical Research Council & GlaxoSmithKline Clinician Scientist Fellowship. Valued at nearly £2m it will help address lung injury, that can lead to acute respiratory distress syndrome. More⬇️ https://t.co/Zr88EXg6QW
0
4
11
📢We are seeking a #Postdoctoral Research Associate with expertise in mass #spectrometry-based #protein #analysis. Apply ➡️ https://t.co/I0W6XV1hEI
@LivUniHLS @LivUniISMIB @LivUniResearch
0
3
6
New Centre for Excellence in Regulatory Science and Innovation in #Pharmacogenomics to help UK move towards personalised prescribing: https://t.co/Xa6lnOqXcf
0
3
6
💊Marvellous Medicine Badge Days @pandtuol ⚜️29/3/25 Scouting ☘️10/5/25 Girlguiding 🧪A full day of hands on science activities showcasing how we make new medicines. Bookings open 1/2/25 https://t.co/3tvqSpOR5e
#marvellousmedicinebadge @livunipharma @livuniengagehls
0
2
5
📢We’re seeking to recruit a Trial Administrative Support to assist the trial management team in carrying out administrative duties for various ongoing clinical trials. Apply ➡️ https://t.co/FK4CMhHKtp
@LivUniHLS @LivUniISMIB
0
1
3
If you are in @LivUniHLS, we need YOU! The Faculty are applying for the Engage Watermark Award, so please fill out the survey - your feedback will help inform the level of award we get! https://t.co/Y97Pi3fDhV
@LivUni_IVES @LivUniISMIB @LivuniILCaMS @LivUniIPH
0
7
3
📢We are seeking applications from candidates with a track record and interests that are aligned to the NIHR 2023-24 priority research theme of “#Prevention and #Public #Health”. Apply➡️ https://t.co/y6he71IMfn
@LivUniHLS @NIHRresearch
0
1
2
NEWS | @LivUni scientists and collaborators have highlighted the most effective treatments for neurological diseases by overcoming one of medicine’s most difficult challenges: the blood–brain barrier🩸 Read more ⬇️ https://t.co/OTrQw3eNCt
0
5
13
Help to develop a new swallowing training programme for head & neck cancer If you have completed treatment for head & neck cancer & can drink fluids & live in Cheshire & Merseyside we’d love to chat to you about a new research project. Dr Lawton michelle.lawton@liverpool.ac.uk
0
8
10
🚀 Hot off the press! Our latest findings from @LivUniISMIB on brain ageing unveil a novel connection between oxidative stress, neuronal microtubules, and the cytoskeletal protein EB1 driving neuronal atrophy. 🎉 A huge thank you to the fantastic team! https://t.co/jzqTg7BF2J
aginganddisease.org
Axons are crucial for transmitting neurochemical signals. As organisms age, the ability of neurons to maintain their axons declines; hence, aged axons are more susceptible to damage or dysfunction....
1
4
19
New research will investigate how the gut microbiome affects rectal cancer's response to radiotherapy. The pilot study will involve @CCCNHS patients and is funded by @GutsCharityUK ➡️ https://t.co/3ivDqkGGdt
#CancerResearch | #TeamLivUni
0
3
9
Join Professor Richard Scheltema (@xlinkx_pd) for his inaugural lecture, "Using Proteomics to Visualise the Intricate Protein Landscape" Register your place: https://t.co/sZ2rAyaKwK… 🗓️Wednesday 26 February 🕔17:00 - 19:00 #TeamLivUni
0
2
0